CIK: 0001536054
Total reported value
$46.3M
Reporting period: 2026-03-31 · Number of holdings: 3
Crestline Management, L.P. disclosed 3 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $46.3M and a quarterly turnover rate of 14.2%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "C"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add DNLI
-21.3% -$4.0M
Trim SANA
-38.1% -$2.8M
Trim EGHT
+0.0% -$307.2K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | DNLI | Denali Therapeutics INC | Stock-Other | 91.74% | +4.72% | -21.35% | |
| 2 | SANA | Sana Biotechnology INC | Stock-Other | 4.70% | -4.62% | -38.10% | |
| 3 | EGHT | 8x8 INC | Stock-Other | 3.56% | -0.10% | +0.03% |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 5% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 3 | $46.3M | 14 | |
| 2025-12-31 | 3 | $53.3M | 9 | |
| 2025-09-30 | 3 | $58.1M | 15 | |
| 2025-06-30 | 3 | $62.6M | 0 | |
| 2025-03-31 | 3 | $63.2M | 100 | |
| 2024-12-31 | 705 | $3.0B | 0 | |
| 2024-09-30 | 514 | $1.9B | 0 | |
| 2024-06-30 | 159 | $1.3B | 0 | |
| 2024-03-31 | 157 | $1.1B | 0 | |
| 2023-12-31 | 157 | $1.2B | 0 | |
| 2023-09-30 | 143 | $858.4M | 0 | |
| 2023-06-30 | 148 | $957.6M | 0 | |
| 2023-03-31 | 157 | $842.1M | 0 | |
| 2022-12-31 | 165 | $682.4M | 0 | |
| 2022-09-30 | 201 | $739.8M | 0 | |
| 2022-06-30 | 221 | $766.4M | 0 | |
| 2022-03-31 | 256 | $834.0M | 0 | |
| 2021-12-31 | 227 | $1.3B | 0 | |
| 2021-09-30 | 236 | $1.1B | 0 | |
| 2021-06-30 | 177 | $1.2B | 81 | |
| 2021-03-31 | 98 | $787.5M | 96 | |
| 2020-12-31 | 141 | $943.0M | 91 | |
| 2020-09-30 | 91 | $678.3M | 72 | |
| 2020-06-30 | 160 | $545.6M | 64 | |
| 2020-03-31 | 32 | $347.5M | 98 | |
| 2019-12-31 | 41 | $772.3M | 86 | |
| 2019-09-30 | 79 | $620.9M | 69 | |
| 2019-06-30 | 82 | $742.6M | 66 | |
| 2019-03-31 | 3 | $461.1M | 57 | |
| 2018-12-31 | 91 | $661.3M | 76 | |
| 2018-09-30 | 139 | $1.1B | 100 | |
| 2018-06-30 | 232 | $951.7M | 81 | |
| 2018-03-31 | 210 | $803.8M | 94 | |
| 2017-12-31 | 157 | $976.2M | 100 | |
| 2017-09-30 | 120 | $719.4M | 61 | |
| 2017-06-30 | 130 | $746.5M | 58 | |
| 2017-03-31 | 112 | $546.5M | 43 | |
| 2016-12-31 | 82 | $400.7M | 82 | |
| 2016-09-30 | 233 | $788.7M | 57 | |
| 2016-06-30 | 1 | $666.9M | 2 | 148205A |
| 2016-03-31 | 1 | $653.9M | 54 | 148205A |
| 2015-12-31 | 1 | $1.1B | 7 | 148205A |
| 2015-09-30 | 1 | $1.1B | 27 | 148205A |
| 2015-06-30 | 1 | $1.4B | 17 | 148205A |
| 2015-03-31 | 1 | $1.6B | 15 | 148205A |
| 2014-12-31 | 1 | $1.4B | 0 | 148205A |
Crestline Management, L.P.'s most significant position changes for 2026-03-31: Trim: Denali Therapeutics INC (DNLI) — shares -21.35%; Trim: Sana Biotechnology INC (SANA) — shares -38.10%; Add: 8x8 INC (EGHT) — shares +0.03%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | DNLI | Denali Therapeutics INC | +4.7% | -21.35% | Trim |
| 2 | EGHT | 8x8 INC | -0.1% | +0.03% | Add |
| 3 | SANA | Sana Biotechnology INC | -4.6% | -38.10% | Trim |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2026-03-31 | 2026-05-15 | Amendment | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-13 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-14 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-12 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-13 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-12 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-13 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-14 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-12 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-13 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-14 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-13 | Amendment | View on EDGAR |
| 2020-03-31 | 2020-05-13 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-12 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-13 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-13 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-14 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-14 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-15 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-14 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-12 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-14 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-14 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-12 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-13 | 13F-HR | View on EDGAR |
| 2015-12-31 | 2016-02-12 | 13F-HR | View on EDGAR |
| 2015-09-30 | 2015-11-12 | 13F-HR | View on EDGAR |
| 2015-06-30 | 2015-07-17 | 13F-HR | View on EDGAR |
| 2015-03-31 | 2015-07-14 | 13F-HR | View on EDGAR |
| 2014-12-31 | 2015-07-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001410830
Total reported value
$46.3M
1 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001537403
Total reported value
$46.4M
2 stks
2019-12-31
Stale — no recent filing
AUM within 0.2% of this institution
CIK 0001320294
Total reported value
$46.1M
5 stks
2014-09-30
Stale — no recent filing
AUM within 0.3% of this institution
Institutions with overlapping top holdings
CIK 0001400240
Total reported value
$1.2B
7 stks
2026-03-31
1 of the top 5 holdings overlap, including Sana Biotechnology INC
CIK 0001910456
Total reported value
$632.7M
23 stks
2026-03-31
1 of the top 5 holdings overlap, including Denali Therapeutics INC
CIK 0002013341
Total reported value
$460.3M
17 stks
2026-03-31
1 of the top 5 holdings overlap, including Denali Therapeutics INC